A Study of Molidustat for Correction of Renal Anemia in Non-dialysis Subjects

NCT03350321 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

162

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia
Renal Insufficiency, Chronic

Interventions

DRUG: Molidustat (BAY85-3934)
DRUG: Darbepoetin alfa

Sponsor

Bayer